Refine by
Neurology Condition Articles & Analysis
54 news found
The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare neurological conditions with a primary focus on epilepsy. Furthermore, a nutraceutical version of the formulation, Mentanine™, is scheduled for clinical studies to investigate its potential applications ...
Performed by neurosurgeon Mark Luciano MD, PhD at The Johns Hopkins Hospital in Baltimore, Maryland, the patient previously required multiple brain surgeries to manage their “Idiopathic Intracranial Hypertension (IIH),” also referred to as “pseudotumor cerebri” because symptoms mimic those of a brain tumor. IIH is a chronic neurological ...
This comprehensive collection provides researchers with a unique resource to study various neurological conditions and accelerate their investigations into neurological diseases and disorders. ...
Surgeons at Intermountain Primary Children’s Hospital are the first in the nation to successfully implant a new brain shunt accessory for young patients with hydrocephalus, a neurological condition that causes a buildup of cerebrospinal fluid in the deep cavities of the brain that often causes frequent hospitalizations. ...
NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL ...
The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder "PTSD", including addiction. ...
Performed by neurosurgeon Samuel Cheshier, MD, at Intermountain Primary Children’s Hospital in Salt Lake City, the patient previously required at least 11 brain surgeries to manage their hydrocephalus, a chronic neurological condition in which excess CSF accumulates in the brain, often causing severe symptoms, frequent hospitalizations, and ongoing health ...
Canaquest Medical Corp (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced that it has been awarded the Best Global Medical Cannabinoid Development Company 2023, in its eighth annual Healthcare and Pharmaceutical ...
Amin Kassam, the CEO of Neeka, a true pioneer in novel surgical procedures, neurological disorders, and innovative health solutions, led the creation and development of the Neeka platform. ...
Medical probiotic leader Bened Biomedical Co., Ltd., which develops and markets neuroactive probiotic products, announced a completed Series A round of fundraising, receiving more than $10 million of capital from two prominent investors, Trans-Pacific Technology Fund (TPTF) and JAFCO Asia. With strategic support from these venture capital partners, Bened expects to rapidly expand its ...
” About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster ...
Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum Date: Thursday, November 17, 2022 Event: One-on-one meetings About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple ...
About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and ...
On Day 1, these abnormal volume changes were 13% and 55% (p National Institute of Neurological Disorders and Stroke (NINDS). Dr. Afshin Divani, Associate Professor Neurology at the University of New Mexico commented, “We are pleased to have successfully completed this study of nVNS as a possible treatment for TBI and believe our data suggest that nVNS ...
For over a decade, the company and its team have been leaders in the design, testing and manufacture of innovative, non-invasive drug delivery systems, particularly transdermal patches and sub-lingual strips for the delivery of active pharmaceutical ingredients for the treatment of pain and neurological conditions. According to Precedence Research, the global ...
According to the World Health Organization, nearly one person in six suffers from some type of neurological condition, amounting to over one billion individuals worldwide. Many neurological conditions can be addressed with medications, but there is still significant unmet medical need. "Neurological disorders ...
Also, in pregnant women, medical conditions that pose risk to the baby result in an increased risk of side effects from local anesthetics, despite being at standard dosages. Certain neurological conditions: General anesthesia risks increase if a person has mental illness, thyroid disease, Parkinson’s disease, Alzheimer’s disease or ...
The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder "PTSD," including addiction. ...
The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder “PTSD,” including addiction.The Company is the industry partner for research and product development with Dr. ...
Inan, and their clinical and research teams at Emory University and Georgia Tech University, as well as the team at NIDA for their support of this study,” commented Eric Liebler, Senior Vice President of Neurology at electroCore. “Opioid addiction strikes individuals, families and society, and we look forward to continuing to partner with NIDA to confirm the potential ...